VYCO Financials 07/16/2014 18:10:52
Vycor Medical, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 1,089 1,205 971 316
Cost of Revenue 154 180 176 49
Gross Profit 936 1,026 795 268
Operating Expenses
Research and Development 53 126 116 15
Sales, General and Admin. 2,813 3,365 4,987 1,977
Non-Recurring Items - - 110 154
Other 351 329 210 57
Operating Income (2,281) (2,794) (4,628) (1,936)
Income From Continuing Operations
Add'l Income/Expense Items - 1 (24) -
Earnings Before Interest and Tax (2,281) (2,793) (4,651) (1,936)
Interest Expense 191 138 127 46
Earnings Before Tax (2,473) (2,931) (4,779) (1,982)
Income Tax - - - 2
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,473) (2,931) (4,779) (1,984)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,473) (2,931) (4,779) (1,984)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,473) (2,931) (4,779) (1,984)